Contraceptives

14 Contraceptives


This is a general term to describe an agent used to prevent conception.


As part of their sphere of practice, midwives have a duty to offer family planning advice (Nursing and Midwifery Council (NMC), 2004; NICE, 2006; Article 42 of the European Union Standards for Nursing and Midwifery, 2009).


The student should be aware of:





BP

Combined oestrogen–progestogen oral contraceptive (COC)

Proprietary

Marvelon® (Merck Sharp & Dohme Ltd), Yasmin® (Bayer PLC), Femodene® (Bayer PLC), Microgynon 30® ED, (Bayer PLC), Ovranette® (Pfizer Ltd), Loestrin 20® and Loestrin 30® (Galen Ltd), Millinette® 20/75 (Consilient Health Ltd)

Group

Contraceptive – hormonal

Uses/indications

Contraception, menstrual symptoms

Type of drug

POM

Presentation

Tablets in packs for 1 month, with days numbered

Dosage

Usually 1 tablet/day, but refer to pack for instructions
Postpartum (not breastfeeding) – commence at 3 weeks’ postpartum – there is an increased risk of DVT if commenced earlier – patient must be fully ambulant, with no puerperal complications, and be counselled for the risk of DVT
Breastfeeding – not recommended until weaning or at least 6 months if unable to obtain other contraception
Miscarriage or abortion – commence on same day if possible

Route of admin

Oral

Contraindications

Pregnancy, migraine, liver disease including cholestatic jaundice, history of pruritus in pregnancy, breastfeeding, prothrombotic coagulation disorders, previous history or strong familial history of DVT, undiagnosed vaginal bleeding, breast or genital tract carcinoma
CAUTION: arterial disease, smoking, hypertension, obesity, diabetes mellitus with retinopathy and nephropathy, ischaemic heart disease, varicosities, depression, inflammatory bowel disease, Rotor syndrome, Dubin–Johnson syndrome, sickle cell anaemia, history of herpes gestationis, disorders of lipid metabolism
Stop prior to major surgery or surgery to the legs, or with long-term immobilization – do not stop for minor surgery with short anaesthetic duration, e.g. laparoscopy or tooth extraction

Side effects

Nausea, vomiting, headache, breast tenderness, changes in body weight, libido changes, DVT, intracycle bleeding, amenorrhoea, decreased menstrual bleeding, depression, impaired liver function

Interactions

Antibiotics – broad spectrum – reduce effect
Anticoagulants – antagonizes the effect of warfarin
Antidepressants – tricyclics – antagonizes the antidepressant effects but increases the side effects because of the increased plasma concentration of tricyclics
Antidiabetics – antagonism of the hypoglycaemic effect
Antiepileptics – carbamazepine, phenobarbital and phenytoin accelerate metabolism and reduce contraceptive effect
Antihypertensives – antagonize hypotensive effect

Pharmacodynamic properties

The combination of these preparations acts to inhibit ovulation by suppressing the mid-cycle surge of luteinizing hormone, thickening the cervical mucus as a barrier to sperm, and rendering the endometrium unresponsive to implantation

Fetal risk

Evidence suggests no harmful effects to fetus, although there is teratogenicity in animals (US studies have found a small risk of 0.07% of all pregnancies exposed to the oral contraceptive pill)

Breastfeeding

Suppressed lactation; contraindicated until at least 6 months after birth


BP

Progestogen-only pill (POP)

Proprietary

Cerazette® (Merck Sharp & Dohme Ltd), Femulen® (Pharmcia Ltd), Micronor® (Janssen Cilag Ltd), Norgeston® (Bayer PLC), Noriday® (Pfizer Ltd)

Group

Contraceptive – hormonal

Uses/indications

Contraception, alternative to oestrogens – higher failure rate, suitable in smokers, hypertension, valvular heart disease, diabetes mellitus, migraine, predisposition to or history of thrombosis or venous thrombosis

Type of drug

POM

Presentation

Tablets in cyclical packs

Dosage

Usually 1 tablet/day, but refer to pack instructions – must be taken at the same time each day
postpartum – commence after 3 weeks – breakthrough bleeding if earlier – women should also be aware of the increased risk of thromboembolic disorders

Route of admin

Oral

Contraindications

Pregnancy, undiagnosed vaginal bleeding, severe arterial disease, existing thrombophlebitis or thromboembolic disorders, cerebrovascular disease, porphyria, heart disease including myocardial infarction, malabsorption syndromes, liver disease, sex steroid-dependent cancers, past ectopic pregnancy, functional ovarian cysts, cholestatic jaundice, pruritus of pregnancy, Dubin–Johnson syndrome, Rotor syndrome, history of herpes gestationis, disorders of lipid metabolism

Side effects

Menstrual irregularities, nausea, vomiting, menstrual symptoms, weight change, depression, dizziness, loss of libido, headaches, chloasma

Interactions

Antibiotics – rifamycins – increase metabolism and therefore reduce effect
Anticoagulants – antagonize effect of warfarin
Antidiabetics – antagonize the hypoglycaemic effects
Antiepileptics – reduce contraceptive effect
St John’s wort – can lead to potential loss of contraceptive effect
< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 11, 2016 | Posted by in MIDWIFERY | Comments Off on Contraceptives

Full access? Get Clinical Tree

Get Clinical Tree app for offline access